EGFR as a stable marker of prostate cancer dissemination to bones

BACKGROUND: Prostate cancer (PCa) is among the most commonly diagnosed malignancies in men. Although 5-year survival in patients with localised disease reaches nearly 100%, metastatic disease still remains incurable. Therefore, there is a need for markers indicating metastatic dissemination. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Nastały, Paulina, Stoupiec, Sara, Popęda, Marta, Smentoch, Julia, Schlomm, Thorsten, Morrissey, Colm, Żaczek, Anna Joanna, Beyer, Burkhard, Tennstedt, Pierre, Graefen, Markus, Eltze, Elke, Maiuri, Paolo, Semjonow, Axel, Pantel, Klaus, Brandt, Burkhard, Bednarz-Knoll, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722745/
https://www.ncbi.nlm.nih.gov/pubmed/32901137
http://dx.doi.org/10.1038/s41416-020-01052-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722745/
https://www.ncbi.nlm.nih.gov/pubmed/32901137
http://dx.doi.org/10.1038/s41416-020-01052-8

Ejemplares similares